Fig. 1From: First clinical experience with fractionated intracavitary radioimmunotherapy using [177Lu]Lu-6A10-Fab fragments in patients with glioblastoma: a pilot studyRadioimmunotherapy is applied after standard treatment of glioblastoma. Standard treatment includes surgical resection followed by radiotherapy and chemotherapy. Exemplary MRI, T1 post contrast and FLAIR of a right temporal glioblastoma, without contrast enhancing or [18F]FET-PET positive tumorBack to article page